D.A. Davidson & Co. Eli Lilly & CO Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Eli Lilly & CO stock. As of the latest transaction made, D.A. Davidson & Co. holds 43,893 shares of LLY stock, worth $32.8 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

43,893

Previous 43,054 1.95%

Holding current value

$32.8 Million

Previous $39 Million 0.24%

% of portfolio

0.33%

Previous 0.35%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $647,825 - $805,456	839 Added 1.95%	43,893 $38.9 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $1.47 Million - $1.84 Million	2,027 Added 4.94%	43,054 $39 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $1.49 Million - $1.99 Million	2,508 Added 6.51%	41,027 $31.9 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $2.23 Million - $2.63 Million	4,240 Added 12.37%	38,519 $22.5 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $2.29 Million - $3.16 Million	-5,275 Reduced 13.34%	34,279 $18.4 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $826,694 - $1.11 Million	2,357 Added 6.34%	39,554 $18.6 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $1.06 Million - $1.25 Million	-3,416 Reduced 8.41%	37,197 $12.8 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $453,707 - $528,659	1,411 Added 3.6%	40,613 $14.9 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $1.08 Million - $1.23 Million	-3,641 Reduced 8.5%	39,202 $12.7 Million
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $6,968 - $8,181	25 Added 0.06%	42,843 $13.9 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $1.16 Million - $1.44 Million	4,951 Added 13.07%	42,818 $12.3 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $1.05 Million - $1.3 Million	4,664 Added 14.05%	37,867 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $190,354 - $234,257	859 Added 2.66%	33,203 $7.67 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $1.54 Million - $1.99 Million	-8,506 Reduced 20.82%	32,344 $7.42 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $1.97 Million - $2.55 Million	11,989 Added 41.54%	40,850 $7.63 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $58,446 - $77,338	448 Added 1.58%	28,861 $4.87 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $95,481 - $110,441	653 Added 2.35%	28,413 $4.21 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $409,532 - $492,868	-3,002 Reduced 9.76%	27,760 $4.56 Million
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $50,001 - $61,887	-420 Reduced 1.35%	30,762 $4.27 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $178,556 - $221,158	1,670 Added 5.66%	31,182 $4.1 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $270,071 - $293,768	2,529 Added 9.37%	29,512 $3.3 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $190,780 - $222,689	-1,722 Reduced 6.0%	26,983 $2.99 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $369,215 - $434,593	-3,317 Reduced 10.36%	28,705 $3.64 Million
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $92,556 - $103,691	874 Added 2.81%	32,022 $3.71 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $109,643 - $137,034	1,277 Added 4.28%	31,148 $3.34 Million
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $280,468 - $321,890	-3,705 Reduced 11.03%	29,871 $2.55 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $230,941 - $272,611	-3,112 Reduced 8.48%	33,576 $2.6 Million
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $87,675 - $94,042	1,070 Added 3.0%	36,688 $3.1 Million
Q3 2017 Nov 08, 2017	SELL	$77.07 - $85.54 $22,350 - $24,806	-290 Reduced 0.81%	35,618 $3.05 Million
Q2 2017 Aug 11, 2017	BUY	N/A	35,908	35,908 $0

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account